Home › Waldenstrom Macroglobulinemia › Texas › Dallas
Waldenstrom Macroglobulinemia clinical trials in Dallas, TX
6 studies for Waldenstrom Macroglobulinemia are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
RecruitingPhase 2
- UT Southwestern-Harold C. Simmons Cancer Center ( Site 2730), Dallas
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RecruitingPhase 1
- University of Texas Southwestern, Dallas
Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM
RecruitingPhase 2
- University of Texas Southwestern Medical Center, Dallas
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
RecruitingPhase 1
- UT Southwestern Medical Center, Dallas
Study of SGR-1505 in Mature B-Cell Neoplasms
RecruitingPhase 1
- University of Texas Southwestern, Dallas
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RecruitingPhase 1
- University of Texas Southwestern Medical Center, Dallas
Waldenstrom Macroglobulinemia trials in other cities
- Durham, NC10 studies
- Boston, MA9 studies
- Denver, CO7 studies
- New York City, NY6 studies
- Edison, NJ6 studies
- Houston, TX6 studies
- Columbus, OH5 studies
- Seattle, WA5 studies
- Rochester, MN5 studies
- Milwaukee, WI5 studies
- Queens, NY4 studies
- Baldwin Park, CA4 studies
Other studies in Dallas
- Breast Cancer54 studies
- Non-Small Cell Lung Cancer52 studies
- Heart Failure42 studies
- Metastatic Cancer42 studies
- Cancer (all types)38 studies
- Prostate Cancer36 studies
- Colorectal Cancer33 studies
- Obesity31 studies
- Ovarian Cancer28 studies
- Bladder Cancer27 studies
- Lung Cancer27 studies
- Endometrial Cancer25 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.